Clinical Trials Directory

Trials / Unknown

UnknownNCT05427903

Two Approaches in Enhancing the Efficacy of Inferior Alveolar Nerve Block During Treatment of Mandibular First Permanent Molars With Symptomatic Irreversible Pulpitis

Evaluation of Two Approaches in Enhancing the Efficacy of Inferior Alveolar Nerve Block During Treatment of Mandibular First Permanent Molars With Symptomatic Irreversible Pulpitis: A Randomized Parallel Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Minia University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

The study is designed as a randomized parallel controlled trial with three groups. Participants aged above 18 years with the first permanent molars with symptomatic signs of irreversible pulpitis will be randomly assigned into 3 groups. The first group (experimental group) will be injected with 4% articaine 1:100.000 epinephrine (inferior alveolar nerve block) will be anesthetized using 4% articaine 1:100.000 plus cryotherapy application, and the second group (experimental group) will be anaesthetised with IANB plus buccal infiltration. For the third group (control group), the mandibular molars will be anaesthetized using epinephrine using the inferior alveolar nerve block.

Conditions

Interventions

TypeNameDescription
PROCEDURECryotherapyIce packs application for 5 minutes after IANB injection
PROCEDUREBuccal local anesthetic infiltration using articaine 4% 1:100000 epinephrineBuccal infiltration after IANB

Timeline

Start date
2022-03-04
Primary completion
2022-06-18
Completion
2022-07-01
First posted
2022-06-22
Last updated
2022-06-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05427903. Inclusion in this directory is not an endorsement.